CN104530232B - 鸭病毒性肝炎精制蛋黄抗体的制备方法 - Google Patents
鸭病毒性肝炎精制蛋黄抗体的制备方法 Download PDFInfo
- Publication number
- CN104530232B CN104530232B CN201410815354.1A CN201410815354A CN104530232B CN 104530232 B CN104530232 B CN 104530232B CN 201410815354 A CN201410815354 A CN 201410815354A CN 104530232 B CN104530232 B CN 104530232B
- Authority
- CN
- China
- Prior art keywords
- duck
- hepatitis
- virus hepatitis
- virus
- yolk
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 241000272525 Anas platyrhynchos Species 0.000 title claims abstract description 142
- 210000002969 egg yolk Anatomy 0.000 title claims abstract description 80
- 206010019799 Hepatitis viral Diseases 0.000 title claims abstract description 78
- 238000002360 preparation method Methods 0.000 title claims abstract description 21
- 239000007788 liquid Substances 0.000 claims abstract description 50
- 238000001914 filtration Methods 0.000 claims abstract description 25
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 18
- 238000004659 sterilization and disinfection Methods 0.000 claims abstract description 18
- 201000010099 disease Diseases 0.000 claims abstract description 16
- 230000002779 inactivation Effects 0.000 claims abstract description 15
- 230000001954 sterilising effect Effects 0.000 claims abstract description 15
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 14
- 229940031551 inactivated vaccine Drugs 0.000 claims abstract description 13
- 238000012545 processing Methods 0.000 claims abstract description 12
- 230000020477 pH reduction Effects 0.000 claims abstract description 8
- 238000005119 centrifugation Methods 0.000 claims abstract description 7
- 241000700605 Viruses Species 0.000 claims description 54
- 208000006454 hepatitis Diseases 0.000 claims description 36
- 231100000283 hepatitis Toxicity 0.000 claims description 36
- 241001557656 Duck hepatitis A virus 1 Species 0.000 claims description 27
- 102000002322 Egg Proteins Human genes 0.000 claims description 22
- 108010000912 Egg Proteins Proteins 0.000 claims description 22
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 22
- 235000013345 egg yolk Nutrition 0.000 claims description 18
- 235000013601 eggs Nutrition 0.000 claims description 17
- 238000006386 neutralization reaction Methods 0.000 claims description 16
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 15
- 230000005847 immunogenicity Effects 0.000 claims description 12
- OBETXYAYXDNJHR-UHFFFAOYSA-N alpha-ethylcaproic acid Natural products CCCCC(CC)C(O)=O OBETXYAYXDNJHR-UHFFFAOYSA-N 0.000 claims description 11
- 238000000926 separation method Methods 0.000 claims description 11
- 210000002257 embryonic structure Anatomy 0.000 claims description 10
- 238000003306 harvesting Methods 0.000 claims description 9
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 9
- 229920000053 polysorbate 80 Polymers 0.000 claims description 9
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 8
- 238000012797 qualification Methods 0.000 claims description 7
- 238000011081 inoculation Methods 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 6
- 239000008351 acetate buffer Substances 0.000 claims description 5
- 238000002266 amputation Methods 0.000 claims description 5
- BHZOKUMUHVTPBX-UHFFFAOYSA-M sodium acetic acid acetate Chemical compound [Na+].CC(O)=O.CC([O-])=O BHZOKUMUHVTPBX-UHFFFAOYSA-M 0.000 claims description 5
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 claims description 4
- 229960000583 acetic acid Drugs 0.000 claims description 4
- 229940040526 anhydrous sodium acetate Drugs 0.000 claims description 4
- 239000012362 glacial acetic acid Substances 0.000 claims description 4
- 239000002574 poison Substances 0.000 claims description 4
- 231100000614 poison Toxicity 0.000 claims description 4
- 244000144992 flock Species 0.000 claims description 3
- 239000006228 supernatant Substances 0.000 claims description 3
- 239000000654 additive Substances 0.000 claims 3
- 230000000996 additive effect Effects 0.000 claims 3
- YBCVMFKXIKNREZ-UHFFFAOYSA-N acoh acetic acid Chemical compound CC(O)=O.CC(O)=O YBCVMFKXIKNREZ-UHFFFAOYSA-N 0.000 claims 2
- 239000007853 buffer solution Substances 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- 241001557661 Duck hepatitis A virus 3 Species 0.000 claims 1
- 239000002253 acid Substances 0.000 claims 1
- 239000000872 buffer Substances 0.000 claims 1
- 239000003795 chemical substances by application Substances 0.000 claims 1
- 230000001934 delay Effects 0.000 claims 1
- 239000012467 final product Substances 0.000 claims 1
- 238000011010 flushing procedure Methods 0.000 claims 1
- 238000007789 sealing Methods 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 claims 1
- 230000002588 toxic effect Effects 0.000 claims 1
- 201000001862 viral hepatitis Diseases 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 13
- 239000000427 antigen Substances 0.000 abstract description 11
- 102000036639 antigens Human genes 0.000 abstract description 11
- 108091007433 antigens Proteins 0.000 abstract description 11
- 229960005486 vaccine Drugs 0.000 abstract description 9
- 206010015856 Extrasystoles Diseases 0.000 abstract description 2
- 230000002860 competitive effect Effects 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 230000028993 immune response Effects 0.000 abstract description 2
- 230000006058 immune tolerance Effects 0.000 abstract description 2
- 150000002632 lipids Chemical class 0.000 abstract description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 32
- 238000012360 testing method Methods 0.000 description 24
- 230000034994 death Effects 0.000 description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 13
- 239000000706 filtrate Substances 0.000 description 12
- 238000007689 inspection Methods 0.000 description 11
- 210000004185 liver Anatomy 0.000 description 11
- 238000002347 injection Methods 0.000 description 10
- 239000007924 injection Substances 0.000 description 10
- 241000204031 Mycoplasma Species 0.000 description 9
- 230000033228 biological regulation Effects 0.000 description 9
- 239000008215 water for injection Substances 0.000 description 9
- 241000287828 Gallus gallus Species 0.000 description 8
- 235000013330 chicken meat Nutrition 0.000 description 8
- 239000003921 oil Substances 0.000 description 8
- 239000000047 product Substances 0.000 description 8
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 238000001514 detection method Methods 0.000 description 7
- 210000001161 mammalian embryo Anatomy 0.000 description 7
- 230000001575 pathological effect Effects 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 238000010255 intramuscular injection Methods 0.000 description 5
- 239000007927 intramuscular injection Substances 0.000 description 5
- 238000003860 storage Methods 0.000 description 5
- 230000003612 virological effect Effects 0.000 description 5
- 238000004500 asepsis Methods 0.000 description 4
- 230000000740 bleeding effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 210000003278 egg shell Anatomy 0.000 description 4
- 230000014759 maintenance of location Effects 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- 238000005303 weighing Methods 0.000 description 4
- 230000003321 amplification Effects 0.000 description 3
- 208000022531 anorexia Diseases 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000004140 cleaning Methods 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 238000002224 dissection Methods 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000003199 nucleic acid amplification method Methods 0.000 description 3
- 206010030899 opisthotonus Diseases 0.000 description 3
- 239000002504 physiological saline solution Substances 0.000 description 3
- 239000002699 waste material Substances 0.000 description 3
- 241001492342 Anatid alphaherpesvirus 1 Species 0.000 description 2
- 206010012735 Diarrhoea Diseases 0.000 description 2
- 241001503699 Muscovy duck parvovirus Species 0.000 description 2
- 235000011054 acetic acid Nutrition 0.000 description 2
- 150000001243 acetic acids Chemical class 0.000 description 2
- 230000004520 agglutination Effects 0.000 description 2
- 230000003115 biocidal effect Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 238000011835 investigation Methods 0.000 description 2
- 230000013011 mating Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- DGPIGKCOQYBCJH-UHFFFAOYSA-M sodium;acetic acid;hydroxide Chemical compound O.[Na+].CC([O-])=O DGPIGKCOQYBCJH-UHFFFAOYSA-M 0.000 description 2
- 230000009385 viral infection Effects 0.000 description 2
- 239000003643 water by type Substances 0.000 description 2
- 208000027312 Bursal disease Diseases 0.000 description 1
- 208000003322 Coinfection Diseases 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 208000006758 Marek Disease Diseases 0.000 description 1
- 241001148547 Mycoplasma gallinarum Species 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- CEGOLXSVJUTHNZ-UHFFFAOYSA-K aluminium tristearate Chemical compound [Al+3].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CEGOLXSVJUTHNZ-UHFFFAOYSA-K 0.000 description 1
- 229940063655 aluminum stearate Drugs 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 206010064097 avian influenza Diseases 0.000 description 1
- 208000004668 avian leukosis Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 239000011324 bead Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000012267 brine Substances 0.000 description 1
- 206010006451 bronchitis Diseases 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000003053 immunization Effects 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000003475 lamination Methods 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal effect Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 210000002976 pectoralis muscle Anatomy 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 238000003757 reverse transcription PCR Methods 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
Landscapes
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410815354.1A CN104530232B (zh) | 2014-12-23 | 2014-12-23 | 鸭病毒性肝炎精制蛋黄抗体的制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410815354.1A CN104530232B (zh) | 2014-12-23 | 2014-12-23 | 鸭病毒性肝炎精制蛋黄抗体的制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN104530232A CN104530232A (zh) | 2015-04-22 |
CN104530232B true CN104530232B (zh) | 2018-05-01 |
Family
ID=52845892
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410815354.1A Active CN104530232B (zh) | 2014-12-23 | 2014-12-23 | 鸭病毒性肝炎精制蛋黄抗体的制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104530232B (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105367654A (zh) * | 2015-12-08 | 2016-03-02 | 天津瑞普生物技术股份有限公司 | 一种i型鸭肝炎精制卵黄抗体制备方法 |
CN105950564B (zh) * | 2016-05-03 | 2019-11-08 | 重庆三杰众鑫生物工程有限公司 | 番鸭肝炎病毒及应用该病毒制备番鸭肝炎病毒精制卵黄抗体的方法 |
CN105854009A (zh) * | 2016-05-03 | 2016-08-17 | 重庆三杰众鑫生物工程有限公司 | 应用番鸭肝炎病毒制备灭活疫苗的制备方法 |
CN106563125B (zh) * | 2016-10-21 | 2020-03-20 | 哈药集团生物疫苗有限公司 | 鸭甲肝病毒ⅲ型复合物活疫苗及其制备方法 |
CN110129285B (zh) * | 2019-05-29 | 2022-12-13 | 商丘美兰生物工程有限公司 | 一种高效筛选鸭肝炎病毒毒种的方法 |
CN112375747B (zh) * | 2020-11-18 | 2022-11-01 | 辽宁益康生物股份有限公司 | 一种鸭病毒性肝炎病毒疫苗株、疫苗及疫苗制备方法 |
CN112961835B (zh) * | 2021-02-25 | 2022-12-09 | 上海创宏生物科技有限公司 | 一种3型鸭甲型肝炎病毒的强毒株及其应用和灭活疫苗 |
CN113278064B (zh) * | 2021-07-20 | 2021-11-02 | 山东信得科技股份有限公司 | 一种用于胚毒类抗原净化处理的方法及其应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102716484A (zh) * | 2012-05-31 | 2012-10-10 | 郑州后羿制药有限公司 | 一种鸭病毒性肝炎卵黄抗体冻干粉及其制备方法 |
CN106854647B (zh) * | 2012-12-11 | 2021-01-15 | 普莱柯生物工程股份有限公司 | 鸭病毒性肝炎二价蛋黄抗体及其制备方法和应用 |
WO2014134225A2 (en) * | 2013-02-26 | 2014-09-04 | Pronutria, Inc. | Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance |
-
2014
- 2014-12-23 CN CN201410815354.1A patent/CN104530232B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN104530232A (zh) | 2015-04-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN104530232B (zh) | 鸭病毒性肝炎精制蛋黄抗体的制备方法 | |
CN103263666B (zh) | 猪圆环病毒2型、猪支原体肺炎二联灭活疫苗及其制备方法 | |
CN102827275B (zh) | 鸭病毒性肝炎二价精制卵黄抗体的制备方法 | |
CN104922663B (zh) | 一种鸡新城疫和h9亚型禽流感二联疫苗 | |
CN102068694A (zh) | 鸡新城疫、传染性支气管炎、传染性法氏囊病三联灭活疫苗的生产方法 | |
CN108794627A (zh) | 一种鸭呼肠孤病毒精制卵黄抗体的制备方法 | |
CN110251671A (zh) | 鹅星状病毒卵黄抗体复合物及其制备方法 | |
CN106282130A (zh) | 一种i群4型禽腺病毒、灭活疫苗及其制备方法 | |
CN102068695B (zh) | 鸡新城疫、传染性支气管炎、禽流感(h9亚型)、传染性法氏囊病四联灭活疫苗的生产方法 | |
CN101475639B (zh) | 一种防治鸭传染性浆膜炎的混合卵黄抗体及其制备方法 | |
CN105949307B (zh) | 一种用于防治番鸭源小鹅瘟的卵黄抗体 | |
CN105950564A (zh) | 番鸭肝炎病毒及应用该病毒制备番鸭肝炎病毒精制卵黄抗体的方法 | |
CN105031638A (zh) | 一种鸡新城疫、禽流感和传染性法氏囊三联灭活疫苗 | |
CN111420042A (zh) | 一种鸭圆环病毒和腺病毒二联灭活疫苗及其卵黄抗体的制备方法 | |
CN104258389B (zh) | 一种疫苗组合物及其制备方法和应用 | |
CN109097340B (zh) | 一种禽腺病毒、一种四联疫苗及其制备方法 | |
CN103709247A (zh) | 一种ⅰ型、新型鸭肝炎二价卵黄抗体的制备方法及其产品和应用 | |
CN104163858B (zh) | 多杀性巴氏杆菌无细胞抗原、制备方法及其应用 | |
CN103143010B (zh) | 鸡新城疫、禽流感(h9亚型)、大肠埃希氏菌病三联灭活疫苗及其制备方法 | |
CN109207436A (zh) | 一株i群4型禽腺病毒毒株及其应用 | |
CN104069489B (zh) | 鸡新城疫和传染性法氏囊二联灭活疫苗及其制备方法 | |
CN111574625A (zh) | 抗鸡滑液囊支原体疾病的特异性卵黄抗体制备方法和应用 | |
CN106065030A (zh) | 鸡包涵体肝炎的卵黄抗体及其制备方法 | |
CN106190991A (zh) | 一种禽脑脊髓炎病毒、灭活疫苗及其制备方法 | |
CN102139104A (zh) | 鸡新城疫、禽流感(h9亚型)、传染性法氏囊病三联灭活疫苗的生产方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation of refined egg yolk antibody against duck viral hepatitis Effective date of registration: 20211222 Granted publication date: 20180501 Pledgee: Shandong Zhucheng rural commercial bank Limited by Share Ltd. Pledgor: SHANDONG SINDER TECHNOLOGY Co.,Ltd. Registration number: Y2021980015708 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20221223 Granted publication date: 20180501 Pledgee: Shandong Zhucheng rural commercial bank Limited by Share Ltd. Pledgor: SHANDONG SINDER TECHNOLOGY Co.,Ltd. Registration number: Y2021980015708 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: Preparation method of refined egg yolk antibody against duck viral hepatitis Effective date of registration: 20230608 Granted publication date: 20180501 Pledgee: Shandong Zhucheng rural commercial bank Limited by Share Ltd. Pledgor: SHANDONG SINDER TECHNOLOGY Co.,Ltd. Registration number: Y2023980043376 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Granted publication date: 20180501 Pledgee: Shandong Zhucheng rural commercial bank Limited by Share Ltd. Pledgor: SHANDONG SINDER TECHNOLOGY Co.,Ltd. Registration number: Y2023980043376 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right |